Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Dylan Y. Breitkreutz"'
Publikováno v:
Journal of Applied Clinical Medical Physics
Purpose The goal of this work was to develop and test nontoxic electron collimation technologies for clinical use. Methods Two novel technologies were investigated: tungsten‐silicone composite and 3D printed electron cutouts. Transmission, dose uni
Autor:
Maxime Bassenne, Peter G. Maxim, Rakesh Manjappa, Jinghui Wang, Lei Xing, Guillem Pratx, Billy W. Loo, Dylan Y. Breitkreutz, Stavros Melemenidis, Syamantak Khan
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:833-844
Purpose The differential response of normal and tumor tissues to ultrahigh-dose-rate radiation (FLASH) has raised new hope for treating solid tumors but, to date, the mechanism remains elusive. One leading hypothesis is that FLASH radiochemically dep
Publikováno v:
Medical Physics. 48:366-375
PURPOSE The dosimetric properties of inverse Compton (IC) x-ray sources were investigated to determine their utility for stereotactic radiation therapy. METHODS Monte Carlo simulations were performed using the egs brachy user code of EGSnrc. Nominal
Publikováno v:
Physica Medica. 79:103-112
Kilovoltage (kV) x-rays are most commonly used for diagnostic imaging due to their sensitivity to tissue composition. In radiation therapy (RT), due to their fast attenuation, kV x-rays are typically only used for superficial irradiation of skin canc
Autor:
Spencer Bialek, Boris Vojnovic, Dylan Y. Breitkreutz, Christopher Daniel Johnstone, Paul Tsouchlos, Anthony Kavanagh, Zach Rovner, Thilakshan Kanesalingam, Magdalena Bazalova-Carter
Publikováno v:
Medical Physics. 46:2015-2024
The goal of this work was to develop and test a cylindrical tissue-equivalent quality assurance (QA) phantom for micro computed tomography (microCT) image-guided small animal irradiators that overcomes deficiencies of existing phantoms due to its mou
Autor:
Murat Surucu, D. Pham, Bin Han, Alexander L. Chin, Lei Xing, Michael F. Gensheimer, Dylan Y. Breitkreutz, E. Simiele, Daniel T. Chang, Nataliya Kovalchuk, Dante P. I. Capaldi, N. Ngo, Lucas K. Vitzthum
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e548-e549
PURPOSE/OBJECTIVE(S) The first clinical biology-guided radiation therapy (BgRT) system - RefleXion X1 - is installed and is being commissioned for clinical use at our institution. The system delivers 6MV-FFF beam via 50 firing positions at 850 cGy/mi
Autor:
Lawrie Skinner, Rakesh Manjappa, Alexandra Blaney, Edward E. Graves, Samuel Strober, Billy W. Loo, Edgar Englemann, Karl Bush, Kerriann M. Casey, Luis A. Soto, Dylan Y. Breitkreutz, Jinghui Wang, Ryan B. Ko, Suparna Dutt, P.G. Maxim, Stavros Melemenidis, Amy S. Yu
Publikováno v:
Radiat Res
Radiation therapy, along with surgery and chemotherapy, is one of the main treatments for cancer. While radiotherapy is highly effective in the treatment of localized tumors, its main limitation is its toxicity to normal tissue. Previous preclinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d39cfe8f45c1e966205d865cc4bfbf63
https://europepmc.org/articles/PMC7855987/
https://europepmc.org/articles/PMC7855987/
Publikováno v:
Radiat Res
In this work, we investigated the delivery of a clinically acceptable pediatric whole brain radiotherapy plan at FLASH dose rates using two lateral opposing 40-MeV electron beams produced by a practically realizable linear accelerator system. The EGS
Autor:
Magdalena Bazalova-Carter, Dylan Y. Breitkreutz, Marc-André Renaud, Sergei Zavgorodni, Michael D. Weil, Jan Seuntjens
Publikováno v:
Medical Physics. 45:5161-5171
Purpose The objective of this work was to investigate the benefits of using inverse optimization treatment planning for kilovoltage arc therapy (KVAT) and to assess the dosimetric limitations of KVAT. Methods Monte Carlo (MC) calculated, inversely op
Autor:
Stephanie Chow, Dylan Y. Breitkreutz, Rakesh Manjappa, Jinghui Wang, Billy W. Loo, Amy S. Yu, Erinn B. Rankin, Karen Levy, Karl Bush, Joshua T. Eggold, Oliver Dorigo
Publikováno v:
Cancer Research. 80:5357-5357
Objective: Ovarian cancer often presents with advanced stage disease. Despite surgery and chemotherapy, recurrence remains inevitable and prognosis poor. Advances in immunotherapy including programmed cell death-1 (PD-1) inhibition show promise, howe